EP Patent

EP3375784A1 — Aza-dihydro-acridone derivatives

Assigned to Artax Biopharma Inc · Expires 2018-09-19 · 8y expired

What this patent protects

Aza-dihydro-acridone derivatives of formula I, wherein the meaning of R 1 , R' 1 , R 2 and R 3 is that specified in the description, to be used as T cells proliferation inhibitors.

USPTO Abstract

Aza-dihydro-acridone derivatives of formula I, wherein the meaning of R 1 , R' 1 , R 2 and R 3 is that specified in the description, to be used as T cells proliferation inhibitors.

Drugs covered by this patent

Patent Metadata

Patent number
EP3375784A1
Jurisdiction
EP
Classification
—
Expires
2018-09-19
Drug substance claim
No
Drug product claim
No
Assignee
Artax Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.